Open access
Open access
Powered by Google Translator Translator

Cardiology (all articles)

Stress testing and noninvasive coronary imaging: What’s the best test for my patient?

10 Sep, 2021 | 05:01h | UTC

Stress testing and noninvasive coronary imaging: What’s the best test for my patient? – Cleveland Clinic Journal of Medicine

 

Drug-drug interactions with direct oral anticoagulants: practical recommendations for clinicians.

10 Sep, 2021 | 04:59h | UTC

Drug-Drug Interactions with Direct Oral Anticoagulants: Practical Recommendations for Clinicians – The American Journal of Medicine

 

Review: Heart failure with mid-range or mildly reduced ejection fraction.

9 Sep, 2021 | 08:52h | UTC

Heart failure with mid-range or mildly reduced ejection fraction – Nature Reviews Cardiology (free for a limited period)

 

Commentary on Twitter

 

Radiation‐induced cardiovascular disease: review of an underrecognized pathology.

9 Sep, 2021 | 08:54h | UTC

Radiation‐Induced Cardiovascular Disease: Review of an Underrecognized Pathology – Journal of the American Heart Association

 

Recent cannabis use linked to increased risk of myocardial infarction in young adults: a cross-sectional study.

7 Sep, 2021 | 21:38h | UTC

Recent cannabis use and myocardial infarction in young adults: a cross-sectional study – Canadian Medical Association Journal

News release: Recent cannabis use linked to heart attack risk in younger adults – Canadian Medical Association Journal

Commentary: Young adult cannabis consumers nearly twice as likely to suffer from a heart attack, research shows – CNN

 

Systematic review: evaluation of dietary patterns and all-cause mortality.

6 Sep, 2021 | 10:43h | UTC

Evaluation of Dietary Patterns and All-Cause Mortality: A Systematic Review – JAMA Network Open

 

Commentary on Twitter (thread – click for more)

 

Study shows cardiac troponin concentrations at presentation are insufficient to distinguish type 1 myocardial infarction from other causes of myocardial injury.

6 Sep, 2021 | 10:42h | UTC

Cardiac Troponin Thresholds and Kinetics to Differentiate Myocardial Injury and Myocardial Infarction – Circulation

 

Commentary on Twitter

 

AHA Scientific Statement: Genetic testing for heritable cardiovascular diseases in pediatric patients.

6 Sep, 2021 | 10:33h | UTC

Genetic Testing for Heritable Cardiovascular Diseases in Pediatric Patients: A Scientific Statement From the American Heart Association – Circulation: Genomic and Precision Medicine

News release: Genetic testing in children for heart disorders should be family-centered, include counseling – American Heart Association

 

Commentary on Twitter

https://twitter.com/CSHeartResearch/status/1428750055863844866

 

Review: Cardiovascular care of older adults.

3 Sep, 2021 | 10:13h | UTC

Cardiovascular care of older adults – The BMJ

 

Position Paper: Diagnosis and management of heart failure in elderly patients from hospital admission to discharge.

3 Sep, 2021 | 10:11h | UTC

Diagnosis and Management of Heart Failure in Elderly Patients from Hospital Admission to Discharge: Position Paper – Journal of Clinical Medicine

 

Scientific Statement: Coronavirus Disease-2019 and Heart Failure.

2 Sep, 2021 | 10:08h | UTC

Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America – Journal of Cardiac Failure

 

Commentary on Twitter

 

Expired cardiac devices may do global good, but safety unknown – A discussion of the ethics of using expired technology in parts of the world with no other options is long past due, some say.

2 Sep, 2021 | 08:16h | UTC

Expired Cardiac Devices May Do Global Good, but Safety Unknown – TCTMD

 

#ESCCongress – 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.

31 Aug, 2021 | 08:53h | UTC

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC) – European Heart Journal

News release: How can I avoid heart disease or stroke? – European Society of Cardiology

Key Points: 2021 ESC Guidelines on CVD Prevention in Clinical Practice – American College of Cardiology

 

Commentary on Twitter

 

#ESCCongress – RCT: Influenza vaccination early after a myocardial infarction (MI) or in high-risk coronary heart disease resulted in a lower risk of a composite of all-cause death, MI, or stent thrombosis compared with placebo.

31 Aug, 2021 | 08:52h | UTC

Influenza Vaccination after Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial – Circulation

Commentaries:

IAMI: Influenza Vaccine Beneficial for Post-MI Patients – TCTMD

Influenza Vaccination After Myocardial Infarction – IAMI – American College of Cardiology

Flu vaccine after heart attack reduces risk of death – Cardiovascular Business

 

Commentary on Twitter

 

#ESCCongress – RCT: In older patients with hypertension, intensive treatment with a SBP target of 110 to less than 130 mm Hg resulted in a lower incidence of cardiovascular events than standard treatment with a target of 130 to less than 150 mm Hg.

31 Aug, 2021 | 08:49h | UTC

Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries:

STEP: Aggressive BP Management in Older Chinese Patients With HTN Improved CV Outcomes vs. Standard Care – American College of Cardiology

STrategy of blood pressure intervention in the Elderly hypertensive Patients – STEP – American College of Cardiology

 

Commentary on Twitter

 

#ESCCongress – RCT: In individuals at risk for stroke, screening for atrial fibrillation using loop recorder resulted in a three-times increase in atrial fibrillation detection and anticoagulation initiation but did not reduce the risk of stroke or systemic arterial embolism.

31 Aug, 2021 | 08:50h | UTC

Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial – The Lancet

News release: Continuous heart rhythm monitoring and treatment if indicated does not prevent stroke – European Society of Cardiology

Commentary: Atrial Fibrillation Detected by Continuous ECG Monitoring Using Implantable Loop Recorder to Prevent Stroke in High-Risk Individuals – LOOP – American College of Cardiology

Related: #ESCCongress – RCT: Small benefit from systematic screening for atrial fibrillation in older adults – After a median follow-up of 6.9 y there were fewer events (stroke, embolism, bleeding, and death) in the intervention group (31·9%) vs. control group (33·0%).

 

#ESCCongress – M-A: Polypills with and without aspirin substantially reduce cardiovascular disease, myocardial infarction, stroke, revascularization, and cardiovascular death in primary cardiovascular disease prevention.

31 Aug, 2021 | 08:47h | UTC

Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis – The Lancet (link to abstract – $ for full-text)

Commentary: Combo therapy cuts risk of heart attacks and strokes in half – McMaster University

Related:

Opinion: A new important study supports wider use of the polypill

#AHA20 – Randomized trial: A polypill comprising statins, multiple blood pressure lowering drugs, and aspirin prevents cardiovascular events among patients at intermediate cardiovascular risk

Perspective: Are Polypills and Population-based Treatment the Next Big Things?

The Polypill Revisited: Why We Still Need Population-Based Approaches in the Precision Medicine Era

Randomized Trial: Polypill for Cardiovascular Disease Prevention in an Underserved Population

Randomized Trial: Effectiveness of Polypill for Primary and Secondary Prevention of Cardiovascular Diseases

Clinical Impact of the Polypill for Cardiovascular Prevention in Latin America: A Consensus Statement of the Inter-American Society of Cardiology – Global Heart

Perspective: The Polypill and the Long Journey to Major Impact

Research: Low-Dose ‘Triple Pill’ Lowers Blood Pressure More Than Usual Care

 

#ESCCongress – 2021 ESC/EACTS Guidelines for the management of valvular heart disease – in the new guidelines, more patients are eligible for surgical and transcatheter interventions, based not only on symptoms but also on imaging criteria.

29 Aug, 2021 | 18:23h | UTC

2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) – European Heart Journal

News release: European valvular heart disease Guidelines published today – European Society of Cardiology

Summary: 2021 ESC/EACTS Valvular Heart Disease Guidelines: Key Points – American College of Cardiology

Commentary: Revamped Valve Disease Guideline: Europe Sees Nearly Eye to Eye With U.S. – MedPage Today (free registration required)

“In line with recent U.S. recommendations, the newest European guidelines favor a wider pool of patients eligible for surgical and transcatheter interventions for valvular heart disease.” (from MedPage Today)

 

Commentaries on Twitter

(thread – click for more)

 

#ESCCongress – 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.

29 Aug, 2021 | 18:20h | UTC

2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA) – European Heart Journal

News release: ESC Guidelines on cardiac pacing and cardiac resynchronisation therapy launched today – European Society of Cardiology

See also: European Society of Cardiology Quality Indicators for the care and outcomes of cardiac pacing – EP Europace

 

Commentary on Twitter

 

#ESCCongress – 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure – SGLT2 inhibitors are now recommended for patients with heart failure with reduced ejection fraction regardless of the presence of diabetes.

29 Aug, 2021 | 18:25h | UTC

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC – European Heart Journal

News release: ESC Guidelines on heart failure management launched today – European Society of Cardiology

 

Commentary on Twitter

 

#ESCCongress – Cluster RCT: Among patients at increased risk for stroke, salt substitution (75% sodium chloride and 25% potassium chloride by mass) reduced the rates of stroke, major cardiovascular events, and death from any cause.

29 Aug, 2021 | 19:21h | UTC

Effect of Salt Substitution on Cardiovascular Events and Death – New England Journal of Medicine (link to abstract – $ for full-text)

News release: Low-sodium salt prevents stroke – European Society of Cardiology

Commentary: Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD – TCTMD

 

Commentary on Twitter

 

#ESCCongress – RCT: SGLT2 inhibition reduced the combined risk of cardiovascular death or hospitalization in patients with heart failure and a preserved ejection fraction, regardless of the presence or absence of diabetes.

29 Aug, 2021 | 18:19h | UTC

Empagliflozin in Heart Failure with a Preserved Ejection Fraction – New England Journal of Medicine

News release: Trial reports first successful results for heart failure with preserved ejection fraction – European Society of Cardiology

Commentary: Empagliflozin Outcome Trial in Patients With Chronic Heart Failure With Preserved Ejection Fraction – EMPEROR-Preserved – American College of Cardiology

 

Commentary on Twitter

 

#ESCCongress – RCT: In patients with A. Fibrillation who underwent TAVR, Edoxaban was noninferior to Vit. K Antagonist regarding the composite primary outcome of adverse clinical events, but resulted in a higher incidence of major bleeding.

29 Aug, 2021 | 18:17h | UTC

Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR – New England Journal of Medicine

Commentaries:

ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting – TCTMD

ENVISAGE-TAVI AF: Edoxaban vs. Warfarin Following Heart Valve Replacement – American College of Cardiology

Edoxaban vs. Standard of Care and Their Effects on Clinical Outcomes in Patients Having Undergone Transcatheter Aortic Valve Implantation–Atrial Fibrillation – ENVISAGE-TAVI AF – American College of Cardiology

 

#ESCCongress – RCT: In patients who underwent PCI at high bleeding risk, 1 month of dual antiplatelet therapy was noninferior to the continuation of dual therapy for at least 2 additional months and resulted in a lower incidence of bleeding events.

29 Aug, 2021 | 18:16h | UTC

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk – New England Journal of Medicine

Commentaries:

Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated vs. Standard DAPT Regimen – MASTER DAPT – American College of Cardiology

MASTER-DAPT: Abbreviated DAPT vs. Standard DAPT in High-Risk Patients Post-PCI – American College of Cardiology

 

#ESCCongress – RCT: Immediate coronary angiography after out-of-hospital cardiac arrest without ST-segment elevation did not improve outcomes compared to delayed/selective angiography.

29 Aug, 2021 | 18:12h | UTC

Angiography after Out-of-Hospital Cardiac Arrest without ST-Segment Elevation – New England Journal of Medicine

News release: Trial does not support early coronary angiography in cardiac arrest without ST elevation – European Society of Cardiology

Commentaries:

Angiography After Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation – TOMAHAWK – American College of Cardiology

TOMAHAWK: Immediate Coronary Angiography vs. Delayed Angiography in OHCA Patients Without ST-Segment Elevation – American College of Cardiology

 

Commentary on Twitter

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.